These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

850 related articles for article (PubMed ID: 27681120)

  • 21. Kaposi's Sarcoma-Associated Herpesvirus Latency Locus Renders B Cells Hyperresponsive to Secondary Infections.
    Sin SH; Eason AB; Bigi R; Kim Y; Kang S; Tan K; Seltzer TA; Venkataramanan R; An H; Dittmer DP
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30021906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor has broad signaling effects in primary effusion lymphoma cells.
    Cannon M; Philpott NJ; Cesarman E
    J Virol; 2003 Jan; 77(1):57-67. PubMed ID: 12477810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kaposi's Sarcoma-Associated Herpesvirus Drives a Super-Enhancer-Mediated Survival Gene Expression Program in Primary Effusion Lymphoma.
    Manzano M; Günther T; Ju H; Nicholas J; Bartom ET; Grundhoff A; Gottwein E
    mBio; 2020 Aug; 11(4):. PubMed ID: 32843547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Linking the Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) to human malignancies.
    Kalt I; Masa SR; Sarid R
    Methods Mol Biol; 2009; 471():387-407. PubMed ID: 19109790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kaposi's Sarcoma-Associated Herpesvirus: Epidemiology and Molecular Biology.
    Li S; Bai L; Dong J; Sun R; Lan K
    Adv Exp Med Biol; 2017; 1018():91-127. PubMed ID: 29052134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. K1 gene transformation activities in AIDS-related and classic type Kaposi's sarcoma: Correlation with clinical presentation.
    Tamanaha-Nakasone A; Uehara K; Tanabe Y; Ishikawa H; Yamakawa N; Toyoda Z; Kurima K; Kina S; Tsuneki M; Okubo Y; Yamaguchi S; Utsumi D; Takahashi K; Arakawa H; Arasaki A; Kinjo T
    Sci Rep; 2019 Apr; 9(1):6416. PubMed ID: 31015491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Next-Generation Sequencing Analysis Reveals Differential Expression Profiles of MiRNA-mRNA Target Pairs in KSHV-Infected Cells.
    Viollet C; Davis DA; Reczko M; Ziegelbauer JM; Pezzella F; Ragoussis J; Yarchoan R
    PLoS One; 2015; 10(5):e0126439. PubMed ID: 25942495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. KSHV-Mediated Angiogenesis in Tumor Progression.
    Purushothaman P; Uppal T; Sarkar R; Verma SC
    Viruses; 2016 Jul; 8(7):. PubMed ID: 27447661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endothelial cell- and lymphocyte-based in vitro systems for understanding KSHV biology.
    McAllister SC; Moses AV
    Curr Top Microbiol Immunol; 2007; 312():211-44. PubMed ID: 17089799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kaposi's sarcoma-associated herpesvirus induces Nrf2 during de novo infection of endothelial cells to create a microenvironment conducive to infection.
    Gjyshi O; Bottero V; Veettil MV; Dutta S; Singh VV; Chikoti L; Chandran B
    PLoS Pathog; 2014 Oct; 10(10):e1004460. PubMed ID: 25340789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Global epigenomic analysis of KSHV-infected primary effusion lymphoma identifies functional
    Park A; Oh S; Jung KL; Choi UY; Lee HR; Rosenfeld MG; Jung JU
    Proc Natl Acad Sci U S A; 2020 Sep; 117(35):21618-21627. PubMed ID: 32817485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease.
    Parravicini C; Chandran B; Corbellino M; Berti E; Paulli M; Moore PS; Chang Y
    Am J Pathol; 2000 Mar; 156(3):743-9. PubMed ID: 10702388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kaposi's sarcoma-associated herpesvirus induces sustained NF-kappaB activation during de novo infection of primary human dermal microvascular endothelial cells that is essential for viral gene expression.
    Sadagopan S; Sharma-Walia N; Veettil MV; Raghu H; Sivakumar R; Bottero V; Chandran B
    J Virol; 2007 Apr; 81(8):3949-68. PubMed ID: 17287275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A CRISPR-Cas9 screen identifies mitochondrial translation as an essential process in latent KSHV infection of human endothelial cells.
    Holmes DL; Vogt DT; Lagunoff M
    Proc Natl Acad Sci U S A; 2020 Nov; 117(45):28384-28392. PubMed ID: 33122441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ERK1/2 and MEK1/2 induced by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection.
    Sharma-Walia N; Krishnan HH; Naranatt PP; Zeng L; Smith MS; Chandran B
    J Virol; 2005 Aug; 79(16):10308-29. PubMed ID: 16051824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of Kaposi's Sarcoma-Associated Herpesvirus-Encoded Viral Interleukin-6 by X-Box Binding Protein 1.
    Hu D; Wang V; Yang M; Abdullah S; Davis DA; Uldrick TS; Polizzotto MN; Veeranna RP; Pittaluga S; Tosato G; Yarchoan R
    J Virol; 2016 Jan; 90(1):368-78. PubMed ID: 26491160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kaposi Sarcoma-associated Herpesvirus: mechanisms of oncogenesis.
    Schulz TF; Cesarman E
    Curr Opin Virol; 2015 Oct; 14():116-28. PubMed ID: 26431609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Piracy of prostaglandin E2/EP receptor-mediated signaling by Kaposi's sarcoma-associated herpes virus (HHV-8) for latency gene expression: strategy of a successful pathogen.
    George Paul A; Sharma-Walia N; Kerur N; White C; Chandran B
    Cancer Res; 2010 May; 70(9):3697-708. PubMed ID: 20388794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin-1 Receptor-Associated Kinase (IRAK) Signaling in Kaposi Sarcoma-Associated Herpesvirus-Induced Primary Effusion Lymphoma.
    Seltzer J; Moorad R; Schifano JM; Landis JT; Dittmer DP
    J Virol; 2020 May; 94(10):. PubMed ID: 32161170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oncolytic Reactivation of KSHV as a Therapeutic Approach for Primary Effusion Lymphoma.
    Zhou F; Shimoda M; Olney L; Lyu Y; Tran K; Jiang G; Nakano K; Davis RR; Tepper CG; Maverakis E; Campbell M; Li Y; Dandekar S; Izumiya Y
    Mol Cancer Ther; 2017 Nov; 16(11):2627-2638. PubMed ID: 28847988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.